
The Influence of Lobbying: A Look at Bill Huizenga’s Staff
The interplay between politics and lobbying is a well-known dynamic, especially within the corridors of Capitol Hill. Representative Bill Huizenga of Michigan’s 4th District is a notable example, with at least twelve of his former staff members having transitioned into lobbying roles.
Since taking office in 2011, Rep. Huizenga has seen a number of his aides move from public service to private sector lobbying, often representing powerful industries such as finance, insurance, and pharmaceuticals. These industries are frequently subjects of federal legislation, necessitating registered lobbyists to advocate on their behalf.
Among those who have transitioned from Huizenga’s office to lobbying is Jon DeWitte, Huizenga’s chief of staff for over ten years. DeWitte left in 2022 to become vice president of government affairs at Travelers Insurance. According to public disclosures, Travelers has actively lobbied Congress on a variety of issues, including health care and taxation.
Similarly, Marlis McManus, once Huizenga’s deputy chief of staff, is now lobbying for Vanguard, focusing on investment funds and equity markets. Her career path exemplifies a common route in politics known as revolving-door politics, where individuals move between government roles and private-sector lobbying.
Others have also followed this path. Palmer Rafferty, another former deputy chief of staff, now lobbies for TransUnion, while Martin Van Valkenburg, a past senior advisor, has worked for an aerospace company in a similar capacity. These roles highlight the significant influence former congressional staffers can wield once they enter the private sector.
The Financial Services Committee, on which Huizenga sits, plays a critical role in overseeing industries that his former staff now represent. This duality has drawn criticism for potential conflicts of interest and increased corporate influence over legislative processes.
With at least seven more of Huizenga’s past aides now working as lobbyists, the revolving door phenomenon continues to be a point of contention. This includes a former senior legislative assistant who currently lobbies for major pharmaceutical companies like Bayer and Eli Lilly.
Facing reelection challenges, Huizenga is identified as one of the most vulnerable Republicans by the Democratic Congressional Campaign Committee. His opponent, state Sen. Sean McCann, positions this dynamic as a key campaign focus.
For more information, visit the full report by Heartland Signal here.
The original article appeared on the American Journal News.






